Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.37 USD | -1.60% |
|
-7.26% | +14.00% |
30/04 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
29/04 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.00% | 475M | |
+2.52% | 92.1B | |
-3.16% | 37.92B | |
-12.12% | 32.97B | |
+75.10% | 27.92B | |
-11.32% | 16.14B | |
+1.73% | 14.1B | |
-11.18% | 11.66B | |
+171.57% | 10.29B | |
-50.45% | 9.99B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Stephens Adjusts Price Target on Avid Bioservices to $12 From $15, Maintains Overweight Rating